MEDI5395: A recombinant oncolytic virus with oncolytic and immune modulatory properties

被引：2
|
作者：
Harper, James A. [1 ]
Burke, Shannon [1 ]
Leinster, Andrew [1 ]
Rath, Nicola [1 ]
Cheng, Xing [2 ]
Jin, Hong [2 ]
Wilkinson, Robert W. [1 ]
Carroll, Danielle [3 ]
机构：
[1] Medmmune Ltd, Cambridge, England
[2] Medmmune LLC, South Sanfransisco, CA USA
[3] AstraZeneca Ltd, Cambridge, England
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.SABCS18-1456
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1456
引用
收藏
页数：2
相关论文
共 50 条
  • [1] MEDI5395: An armed oncolytic Newcastle disease virus
    Carroll, Danielle
    Harper, James
    Jon, Travers
    Burke, Shannon
    Franks, Ruth
    Navarro, Christel
    Cheng, Xing
    Wilkinson, Robert
    Jin, Hong
    CANCER RESEARCH, 2017, 77
  • [2] Phase I study of a recombinant attenuated oncolytic virus, MEDI5395 (NDV-GM-CSF), administered systemically in combination with durvalumab in patients with advanced solid tumors
    Davar, Diwakar
    Carneiro, Benedito A.
    Dy, Grace K.
    Sheth, Siddharth
    Borad, Mitesh J.
    Harrington, Kevin J.
    Patel, Sandip P.
    Galanis, Evanthia
    Samson, Adel
    Agrawal, Sonia
    Chen, Zhongying
    Fan, Chunling
    Gong, Maozhen
    Burton, Jenny
    Tu, Eric
    Durham, Nicholas
    Laubscher, Kevin
    Arnaldez, Fernanda
    Zamarin, Dmitriy
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (11)
  • [3] Exploring the immune stimulatory properties of oncolytic Newcastle Disease Virus
    Burke, Shannon
    Franks, Ruth
    Harper, James
    Travers, Jon
    Navarro, Christel
    Cheng, Xing
    Wilkinson, Robert
    Jin, Hong
    Carroll, Danielle
    CANCER RESEARCH, 2017, 77
  • [4] Enhancement of Oncolytic Properties of Recombinant Newcastle Disease Virus Through Antagonism of Cellular Innate Immune Responses
    Zamarin, Dmitriy
    Martinez-Sobrido, Luis
    Kelly, Kaitlyn
    Mansour, Mena
    Sheng, Gang
    Vigil, Adam
    Garcia-Sastre, Adolfo
    Palese, Peter
    Fong, Yuman
    MOLECULAR THERAPY, 2009, 17 (04) : 697 - 706
  • [5] A recombinant oncolytic measles virus for novel virotherapy
    Kai, Chieko
    CANCER SCIENCE, 2018, 109 : 805 - 805
  • [6] Oncolytic Efficacy of a Recombinant Oncolytic Virus Carrying OX40L inHepatocellular Carcinoma
    YANG, Hao
    DENG, Zhuo-Ya
    SUN, Fang
    LEI, Guang-Lin
    CHENG, Jin-Xia
    YU, Hong-Yu
    TIAN, Chong-Yu
    ZHANG, Shao-Geng
    YANG, Peng-Hu
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2022, 49 (12) : 2387 - 2397
  • [7] Oncolytic Viral Therapy for Glioma by Recombinant Sindbis Virus
    Sun, Kangyixin
    Shi, Xiangwei
    Li, Li
    Nie, Xiupeng
    Xu, Lin
    Jia, Fan
    Xu, Fuqiang
    CANCERS, 2023, 15 (19)
  • [8] Recombinant Strains of Oncolytic Vaccinia Virus for Cancer Immunotherapy
    Yasmin Shakiba
    Pavel O. Vorobyev
    Marah Mahmoud
    Azzam Hamad
    Dmitriy V. Kochetkov
    Gaukhar M. Yusubalieva
    Vladimir P. Baklaushev
    Peter M. Chumakov
    Anastasia V. Lipatova
    Biochemistry (Moscow), 2023, 88 : 823 - 841
  • [9] Recombinant Strains of Oncolytic Vaccinia Virus for Cancer Immunotherapy
    Shakiba, Yasmin
    Vorobyev, Pavel O. O.
    Mahmoud, Marah
    Hamad, Azzam
    Kochetkov, Dmitriy V. V.
    Yusubalieva, Gaukhar M. M.
    Baklaushev, Vladimir P. P.
    Chumakov, Peter M. M.
    Lipatova, Anastasia V. V.
    BIOCHEMISTRY-MOSCOW, 2023, 88 (06) : 823 - 841
  • [10] A novel strategy of oncotherapy using a recombinant oncolytic measles virus
    Kai, Chieko
    Sugiyama, Takaaki
    Fujiyuki, Tomoko
    Yoneda, Misako
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S131 - S131
12345